A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To learn if rivoceranib can help to control olfactory neuroblastoma. The safety of this drug in participants with olfactory neuroblastoma will also be studied.
Epistemonikos ID: 92ae539d2699cb857771d14f02e594a2c58e5f81
First added on: May 15, 2024